Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline vs. Venlafaxine XR in Major Depressive Disorder
NCT00179283Phase 3Completed
- Sponsor
- Vanderbilt University
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sertraline in major depressive disorder (MDD) (2 arms), sponsored by Vanderbilt University. Primary endpoints: Hamilton Depression Rating Scale at 8 weeks, Clinical Global Impression - Severity Scale at 8 weeks and 3 more. Started Apr 2002; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00179283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179283.